Jack Cuzick, PhD, of the Wolfson Institute of Preventive Medicine, discusses abstract S3-07, "16-year long-term follow-up of the IBIS-I breast cancer prevention trial."
Ismail Jatoi, MD, PhD, FACS, of the University of Texas Health Science Center and Ann H. Partridge, MD, MPH, of the Dana-Farber Cancer Institute discuss the increa...
Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract P5-19-09, “
Edith A. Perez, MD, of the Mayo Clinic Cancer Center, discusses abstract S1-06,
Edith A. Perez, MD, on Stromal Tumor-Infiltrating Lymphocytes in Early-Stage HER2-Positive Breast Cancer
Charles E. Geyer, Jr, MD, FACP, of Massey Cancer Center, discusses abstract S3-08,
Lisa A. Carey, MD, of the UNC Lineberger Comprehensive Cancer Center, addresses further analysis of data from abstract S4-05,
Lisa A. Carey, MD, on the CALGB/Alliance 40603 Trial
Advertisement
Advertisement
Jun
Today In Oncology22
Advertisement
